{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:42:18Z","timestamp":1777585338687,"version":"3.51.4"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Indonesia Endowment Fund for Education","award":["PRJ-2361\/LPDP\/2015"],"award-info":[{"award-number":["PRJ-2361\/LPDP\/2015"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Current intervention programme to improve drug adherence are either too complex or expensive for implementation and scale-up in low-middle-income countries. The aim of this study is to assess the process and effects of implementing a low-cost, targeted and tailored pharmacist intervention among patients with type 2 diabetes who are non-adherent to antihypertensive drugs in a real-world primary care Indonesian setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>A cluster randomised controlled trial with a 3-month follow-up will be conducted in 10 community health centres (CHCs) in Indonesia. Type 2 diabetes patients aged 18 years and older who reported non-adherence to antihypertensive drugs according to the Medication Adherence Report Scale (MARS) are eligible to participate. Patients in CHCs randomised to the intervention group will receive a tailored intervention based on their personal adherence barriers. Interventions may include reminders, habit-based strategies, family support, counselling to educate and motivate patients, and strategies to address other drug-related problems. Interventions will be provided at baseline and at a 1-month follow-up. Simple question-based flowcharts and an innovative adherence intervention wheel are provided to support the pharmacy staff. Patients in CHCs randomised to the control group will receive usual care based on the Indonesian guideline. The primary outcome is the between-group difference in medication adherence change from baseline to 3-month follow-up assessed by MARS. Secondary outcomes include changes in patients\u2019 blood pressure, their medication beliefs assessed by the Beliefs about Medicines Questionnaire (BMQ)-specific, as well as process characteristics of the intervention programme from a pharmacist and patient perspective.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Ethical approval was obtained from the Ethical Committee of Universitas Padjadjaran, Indonesia (No. 859\/UN6.KEP\/EC\/2019) and all patients will provide written informed consent prior to participation. The findings of the study will be disseminated through international conferences, one or more peer-reviewed journals and reports to key stakeholders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT04023734\">NCT04023734<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2019-034507","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T23:28:02Z","timestamp":1578439682000},"page":"e034507","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct04023734","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5419-8938","authenticated-orcid":false,"given":"Sofa D","family":"Alfian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizky","family":"Abdulah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Denig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job F M","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"2020050713292686000_10.1.e034507.1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-S010"},{"key":"2020050713292686000_10.1.e034507.2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jash.2013.07.006","article-title":"Perception of uncontrolled blood pressure and non-adherence to anti-hypertensive agents in diabetic hypertensive patients","volume":"7","author":"Ledur","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"2020050713292686000_10.1.e034507.3","unstructured":"Khan R , Socha-Dietrich K . Investing in medication adherence improves health outcomes and health system efficiency: adherence to medicines for diabetes, hypertension, and hyperlipidaemia. OECD Heal Work Pap 2018."},{"key":"2020050713292686000_10.1.e034507.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.10.038"},{"key":"2020050713292686000_10.1.e034507.5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pec.2007.10.016","article-title":"Comparison of individual perceptions of medication costs and benefits between intentional and unintentional medication non-adherence among Japanese patients","volume":"70","author":"Iihara","year":"2008","journal-title":"Patient Educ Couns"},{"key":"2020050713292686000_10.1.e034507.6","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015866415552"},{"key":"2020050713292686000_10.1.e034507.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2007.05.004"},{"key":"2020050713292686000_10.1.e034507.8","unstructured":"Sabate E . Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003."},{"key":"2020050713292686000_10.1.e034507.9","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3258-72-1"},{"key":"2020050713292686000_10.1.e034507.10","doi-asserted-by":"crossref","unstructured":"Nieuwlaat R , Wilczynski N , Navarro T , et al . Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014:CD000011.doi:10.1002\/14651858.CD000011.pub4","DOI":"10.1002\/14651858.CD000011.pub4"},{"key":"2020050713292686000_10.1.e034507.11","doi-asserted-by":"crossref","unstructured":"Kini V , Ho PM . Interventions to improve medication adherence: a review. JAMA 2018;320.doi:10.1001\/jama.2018.19271","DOI":"10.1001\/jama.2018.19271"},{"key":"2020050713292686000_10.1.e034507.12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1331\/JAPhA.2012.10211","article-title":"Targeting cardiovascular medication adherence interventions","volume":"52","author":"Cutrona","year":"2012","journal-title":"J Am Pharm Assoc"},{"key":"2020050713292686000_10.1.e034507.13","first-page":"786","article-title":"Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence","volume":"20","author":"van Boven","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"key":"2020050713292686000_10.1.e034507.14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ypmed.2017.03.008","article-title":"Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis","volume":"99","author":"Conn","year":"2017","journal-title":"Prev Med"},{"key":"2020050713292686000_10.1.e034507.15","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/hsc.12289","article-title":"Community pharmacy and emerging public health initiatives in developing Southeast Asian countries: a systematic review","volume":"24","author":"Hermansyah","year":"2016","journal-title":"Health Soc Care Community"},{"key":"2020050713292686000_10.1.e034507.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5661"},{"key":"2020050713292686000_10.1.e034507.17","doi-asserted-by":"crossref","unstructured":"Chan A-W , Tetzlaff JM , G\u00f8tzsche PC , et al . Spirit 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586.doi:10.1136\/bmj.e7586","DOI":"10.1136\/bmj.e7586"},{"key":"2020050713292686000_10.1.e034507.18","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.89.9.1322"},{"key":"2020050713292686000_10.1.e034507.19","unstructured":"Indonesia KKR . Peraturan Menteri Kesehatan Republik Indonesia Nomor 74 Tahun 2016. Jakarta: Tentang Standar Pelayanan Kefarmasian Di Puskesmas, 2016. http:\/\/jdih.pom.go.id\/produk\/peraturan menteri\/PMK_No._74_ttg_Standar_Pelayanan_Kefarmasian_di_PUSKESMAS_.pdf"},{"key":"2020050713292686000_10.1.e034507.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2005.00568.x"},{"key":"2020050713292686000_10.1.e034507.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-3991(98)00107-4"},{"key":"2020050713292686000_10.1.e034507.22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/jhh.2017.48","article-title":"Factors associated with antihypertensive medication non-adherence: a systematic review","volume":"31","author":"van der Laan","year":"2017","journal-title":"J Hum Hypertens"},{"key":"2020050713292686000_10.1.e034507.23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/JCN.0000000000000582","article-title":"Factors associated with nonadherence to cardiovascular medications: a cross-sectional study","volume":"34","author":"van der Laan","year":"2019","journal-title":"J Cardiovasc Nurs"},{"key":"2020050713292686000_10.1.e034507.24","doi-asserted-by":"crossref","unstructured":"van Boven JFM , Lavorini F , Dekhuijzen PNR , et al . Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the first European Congress on adherence to therapy. Eur Respir J 2017;49:1700076.doi:10.1183\/13993003.00076-2017","DOI":"10.1183\/13993003.00076-2017"},{"key":"2020050713292686000_10.1.e034507.25","first-page":"176","article-title":"Uji validitas dan reliabilitas kuesioner medication adherence report scale (MARS) terhadap pasien diabetes mellitus [in Bahasa Indonesia]","volume":"2","author":"Alfian","year":"2017","journal-title":"J Ilm Ibnu Sina"},{"key":"2020050713292686000_10.1.e034507.26","doi-asserted-by":"publisher","DOI":"10.1080\/08870449908407311"},{"key":"2020050713292686000_10.1.e034507.27","doi-asserted-by":"crossref","unstructured":"Birtcher K . When compliance is an issue-how to enhance statin adherence and address adverse effects. Curr Atheroscler Rep 2015;17:471.doi:10.1007\/s11883-014-0471-8","DOI":"10.1007\/s11883-014-0471-8"},{"key":"2020050713292686000_10.1.e034507.28","doi-asserted-by":"publisher","DOI":"10.1177\/1060028013501146"},{"key":"2020050713292686000_10.1.e034507.29","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv113"},{"key":"2020050713292686000_10.1.e034507.30","first-page":"208","article-title":"Evaluasi kepatuhan pasien diabetes melitus tipe 2 di Rumah Sakit Umum PKU Muhammadiyah Bantul, Yogyakarta [in Bahasa Indonesia]","volume":"11","author":"Adikusuma","year":"2014","journal-title":"Media Farm"},{"key":"2020050713292686000_10.1.e034507.31","first-page":"106","article-title":"A randomised controlled trial to test the effectiveness of planning strategies to improve medication adherence in patients with cardiovascular disease","volume":"9","author":"Meslot","year":"2017","journal-title":"Appl Psychol"},{"key":"2020050713292686000_10.1.e034507.32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.11124\/jbisrir-2016-2296","article-title":"The effectiveness of the teach-back method on adherence and self-management in health education for people with chronic disease: a systematic review","volume":"14","author":"Ha Dinh","year":"2016","journal-title":"JBI Database System Rev Implement Rep"},{"key":"2020050713292686000_10.1.e034507.33","unstructured":"Rollnick S , Miller WR , Arkowitz H , et al . Motivational Interviewing in Health Care: Helping Patients Change Behavior. New York: The Guilford Press, 2008. http:\/\/www.monarchsystem.com\/wp-content\/uploads\/2012\/06\/Motivational-Interviewing-in-Health-Care-Resource-Book.pdf"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-034507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T16:14:26Z","timestamp":1601050466000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-034507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,10]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/bmjopen-2019-034507"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-034507","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}